{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:12:18Z","timestamp":1793506338849,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.cancergen.2011.06.002","type":"journal-article","created":{"date-parts":[[2011,8,27]],"date-time":"2011-08-27T02:22:12Z","timestamp":1314411732000},"page":"392-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors"],"prefix":"10.1016","volume":"204","author":[{"given":"Ronald L.","family":"Paquette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Nicoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenal","family":"Chalukya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Sawyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Spiteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouri","family":"Nanjangud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Nagesh","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2011.06.002_bib1","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood.V99.10.3530","article-title":"Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study","volume":"99","author":"Sawyers","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2011.06.002_bib2","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1182\/blood-2006-09-046888","article-title":"Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis","volume":"109","author":"Cortes","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2011.06.002_bib3","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/sj.leu.2400880","article-title":"The EVI1 gene in myeloid leukemia","volume":"11","author":"Nucifora","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2011.06.002_bib4","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1158\/0008-5472.CAN-08-2562","article-title":"EVI1 impairs myelopoiesis by deregulation of PU.1 function","volume":"69","author":"Laricchia-Robbio","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2011.06.002_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR\u2013ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2011.06.002_bib6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/blood-2010-04-281337","article-title":"Aberrant DNA hypermethylation signature in acute myeloid leukemia","volume":"117","author":"Lugthart","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2011.06.002_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR\u2013ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergen.2011.06.002_bib8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1365-2141.2007.06505.x","article-title":"An interphase fluorescence in situ hybridization assay for the detection of 3q26.2\/EVI1 rearrangements in myeloid malignancies","volume":"136","author":"Bobadilla","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2011.06.002_bib9","first-page":"113","article-title":"Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia","volume":"3","author":"Przepiorka","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cancergen.2011.06.002_bib10","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/sj.onc.1202571","article-title":"Determination of cell fate by c-Abl activation in the response to DNA damage","volume":"17","author":"Kharbanda","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2011.06.002_bib11","doi-asserted-by":"crossref","first-page":"12748","DOI":"10.1074\/jbc.274.18.12748","article-title":"Radiation-induced assembly of Rad51 and Rad52 recombination complex required ATM and c-Abl","volume":"274","author":"Chen","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cancergen.2011.06.002_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbrc.2009.03.020","article-title":"c-ABL tyrosine kinase stabilizes RAD51 chromatin association","volume":"382","author":"Shimizu","year":"2009","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1016\/j.cancergen.2011.06.002_bib13","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1182\/blood-2008-04-148791","article-title":"BCR\u2013ABL fusion transcript types\u00a0and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemias","volume":"112","author":"Jones","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2011.06.002_bib14","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1073\/pnas.030421197","article-title":"Human AML1\/MDS1\/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML","volume":"97","author":"Cuenco","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergen.2011.06.002_bib15","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1038\/sj.onc.1205095","article-title":"Cooperation of BCR\u2013ABL and AML\/MDS1\/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia","volume":"20","author":"Cuenco","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2011.06.002_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.gene.2007.04.012","article-title":"The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions","volume":"396","author":"Weiser","year":"2007","journal-title":"Gene"},{"key":"10.1016\/j.cancergen.2011.06.002_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.gene.2006.07.027","article-title":"Conservation and expression of a novel alternatively spliced Evi1 exon","volume":"384","author":"Alzuherri","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.cancergen.2011.06.002_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.onc.1207143","article-title":"Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1\/MDS1\/EVI1 with BCR\/ABL in the induction of acute myelogenous leukemia in mice","volume":"23","author":"Cuenco","year":"2004","journal-title":"Oncogene"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776211001529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776211001529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:35:33Z","timestamp":1761896133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776211001529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S2210776211001529"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2011.06.002","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2011.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}